Related Experiment Video
Updated: Jun 20, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Expression of ABC-transport proteins in canine mammary cancer: consequences for chemotherapy
K U Honscha1, A Schirmer, A Reischauer
1Institute of Veterinary Physiology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Germany. K.honscha@vetmed.uni-leipzig.de
Abstract:
Intrinsic or acquired drug resistance is a major barrier for chemotherapy of cancer. Importantly, the presence of ATP-binding cassette, ABC-transport proteins in tumour cells circumvents an intracellular accumulation of chemotherapeutic drugs. In this study, 103 canine mammary tumour probes were investigated for mRNA expression of seven ABC-transporters by RT-PCR. All tumour samples expressed multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP). MRP7 was detected in 97.1% of tumour probes, MRP3 in 96.1%, Pgp in 92.2%, MRP5 in 85.4% and MRP6 in 64.1%. More of the half of tumour samples (56.1%) expressed all of the examined ABC-transport proteins. Approximately one-third of the tumour samples (32.7%) were lacking in one transporter and only 11.2% possessed from three to five transporters. The canine transporter cBCRP was functionally analysed in stable transfected Madin-Darby canine kidney-II cells using an MTT viability test. cBCRP transfected cells showed a 5.4-fold resistance to 10 microm doxorubicin. Cell survival in the presence of methotrexate was not affected by cBCRP. In conclusion, absence of efficiency of chemotherapy of canine mammary cancer can be caused by expression of seven various ABC-transport proteins. Because cBCRP is expressed in all examined tumour probes and induces resistance to doxorubicin, the application of doxorubicin for treatment of canine mammary is inappropriate.
Insights
Drug resistance in canine mammary tumors is often due to ATP-binding cassette (ABC) transporters. These transporters, including multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP), limit chemotherapy effectiveness.
Area of Science:
- Veterinary Oncology
- Molecular Biology
- Cancer Research
Background:
- Drug resistance is a significant challenge in cancer chemotherapy.
- ATP-binding cassette (ABC) transporters in tumor cells can prevent the accumulation of chemotherapeutic agents.
- Understanding ABC transporter expression in canine mammary tumors is crucial for effective treatment.
Purpose of the Study:
- To investigate the mRNA expression of seven ABC-transporters in canine mammary tumors.
- To functionally analyze the canine breast cancer resistance protein (cBCRP) and its role in drug resistance.
- To determine the impact of ABC transporter expression on chemotherapy efficacy in canine mammary cancer.
Main Methods:
- RT-PCR was used to analyze the mRNA expression of seven ABC-transporters in 103 canine mammary tumor samples.
- Stable transfection of Madin-Darby canine kidney-II cells with cBCRP was performed.
- MTT viability assays were conducted to assess drug resistance in transfected cells.
Main Results:
- All tumor samples expressed multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP).
- High expression rates were observed for MRP7 (97.1%), MRP3 (96.1%), Pgp (92.2%), MRP5 (85.4%), and MRP6 (64.1%).
- cBCRP-transfected cells exhibited a 5.4-fold resistance to doxorubicin, while methotrexate sensitivity remained unaffected.
Conclusions:
- The expression of seven different ABC-transporters can contribute to the lack of chemotherapy efficacy in canine mammary cancer.
- Given its universal expression in canine mammary tumors and induced doxorubicin resistance, cBCRP is a key factor.
- Doxorubicin may be an inappropriate choice for treating canine mammary cancer due to cBCRP-mediated resistance.
Related Concept Videos
ABC Transporters: Exporter
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

